enzo life sciences (uk) limited
enzo life sciences (uk) limited Company Information
Group Structure
View All
Industry
Other research and experimental development on natural sciences and engineering
Registered Address
1 colleton crescent, exeter, devon, EX2 4DG
Website
www.enzolifesciences.comenzo life sciences (uk) limited Estimated Valuation
Pomanda estimates the enterprise value of ENZO LIFE SCIENCES (UK) LIMITED at £889.5k based on a Turnover of £717.3k and 1.24x industry multiple (adjusted for size and gross margin).
enzo life sciences (uk) limited Estimated Valuation
Pomanda estimates the enterprise value of ENZO LIFE SCIENCES (UK) LIMITED at £0 based on an EBITDA of £-988.5k and a 5.66x industry multiple (adjusted for size and gross margin).
enzo life sciences (uk) limited Estimated Valuation
Pomanda estimates the enterprise value of ENZO LIFE SCIENCES (UK) LIMITED at £0 based on Net Assets of £-3.3m and 2.03x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Enzo Life Sciences (uk) Limited Overview
Enzo Life Sciences (uk) Limited is a live company located in devon, EX2 4DG with a Companies House number of 02584159. It operates in the other research and experimental development on natural sciences and engineering sector, SIC Code 72190. Founded in February 1991, it's largest shareholder is axxora (uk) limited with a 100% stake. Enzo Life Sciences (uk) Limited is a mature, small sized company, Pomanda has estimated its turnover at £717.3k with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Enzo Life Sciences (uk) Limited Health Check
Pomanda's financial health check has awarded Enzo Life Sciences (Uk) Limited a 1 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 8 areas for improvement. Company Health Check FAQs
0 Strong
3 Regular
8 Weak
Size
annual sales of £717.3k, make it smaller than the average company (£3.7m)
- Enzo Life Sciences (uk) Limited
£3.7m - Industry AVG
Growth
3 year (CAGR) sales growth of 1%, show it is growing at a slower rate (5%)
- Enzo Life Sciences (uk) Limited
5% - Industry AVG
Production
with a gross margin of 47.1%, this company has a comparable cost of product (47.1%)
- Enzo Life Sciences (uk) Limited
47.1% - Industry AVG
Profitability
an operating margin of -137.8% make it less profitable than the average company (4.3%)
- Enzo Life Sciences (uk) Limited
4.3% - Industry AVG
Employees
with 7 employees, this is below the industry average (43)
7 - Enzo Life Sciences (uk) Limited
43 - Industry AVG
Pay Structure
on an average salary of £62.3k, the company has an equivalent pay structure (£62.3k)
- Enzo Life Sciences (uk) Limited
£62.3k - Industry AVG
Efficiency
resulting in sales per employee of £102.5k, this is equally as efficient (£115.8k)
- Enzo Life Sciences (uk) Limited
£115.8k - Industry AVG
Debtor Days
it gets paid by customers after 69 days, this is later than average (52 days)
- Enzo Life Sciences (uk) Limited
52 days - Industry AVG
Creditor Days
its suppliers are paid after 11 days, this is quicker than average (42 days)
- Enzo Life Sciences (uk) Limited
42 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Enzo Life Sciences (uk) Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (38 weeks)
0 weeks - Enzo Life Sciences (uk) Limited
38 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 271.9%, this is a higher level of debt than the average (44.4%)
271.9% - Enzo Life Sciences (uk) Limited
44.4% - Industry AVG
ENZO LIFE SCIENCES (UK) LIMITED financials
Enzo Life Sciences (Uk) Limited's latest turnover from July 2023 is estimated at £717.3 thousand and the company has net assets of -£3.3 million. According to their latest financial statements, Enzo Life Sciences (Uk) Limited has 7 employees and maintains cash reserves of £54.9 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jul 2023 | Jul 2022 | Jul 2021 | Jul 2020 | Jul 2019 | Jul 2018 | Jul 2017 | Jul 2016 | Jul 2015 | Jul 2014 | Jul 2013 | Jul 2012 | Jul 2011 | Jul 2010 | Jul 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 1,187,292 | 1,220,720 | |||||||||||||
| Other Income Or Grants | 0 | 0 | |||||||||||||
| Cost Of Sales | 849,839 | 875,023 | |||||||||||||
| Gross Profit | 337,453 | 345,697 | |||||||||||||
| Admin Expenses | 494,337 | 729,698 | |||||||||||||
| Operating Profit | -156,884 | -384,001 | |||||||||||||
| Interest Payable | 0 | 0 | |||||||||||||
| Interest Receivable | 0 | 0 | |||||||||||||
| Pre-Tax Profit | -156,884 | -384,001 | |||||||||||||
| Tax | 0 | -9,872 | |||||||||||||
| Profit After Tax | -156,884 | -393,873 | |||||||||||||
| Dividends Paid | 0 | 0 | |||||||||||||
| Retained Profit | -156,884 | -393,873 | |||||||||||||
| Employee Costs | |||||||||||||||
| Number Of Employees | 7 | 5 | 4 | 5 | 5 | 2 | 3 | 3 | |||||||
| EBITDA* | -156,884 | -384,001 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jul 2023 | Jul 2022 | Jul 2021 | Jul 2020 | Jul 2019 | Jul 2018 | Jul 2017 | Jul 2016 | Jul 2015 | Jul 2014 | Jul 2013 | Jul 2012 | Jul 2011 | Jul 2010 | Jul 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 61,452 | 186,883 | 250,618 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 61,452 | 186,883 | 250,618 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 505,499 | 314,463 | 483,369 |
| Trade Debtors | 136,237 | 105,847 | 261,723 | 159,624 | 282,630 | 142,753 | 187,732 | 196,062 | 129,078 | 1,077,706 | 845,497 | 1,471,744 | 189,344 | 247,278 | 265,839 |
| Group Debtors | 1,673,983 | 1,411,546 | 1,023,637 | 909,495 | 803,482 | 716,466 | 717,506 | 806,349 | 764,974 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 44,000 | 44,000 | 44,000 | 1,828 | 50 | 1,432 | 3,691 | 883 | 349 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 54,944 | 35,336 | 66,670 | 48,864 | 45,793 | 25,339 | 82,947 | 64,941 | 36,914 | 95,661 | 201,897 | 218,711 | 261,831 | 111,477 | 29,365 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 1,909,164 | 1,596,729 | 1,396,030 | 1,119,811 | 1,131,955 | 885,990 | 991,876 | 1,068,235 | 931,315 | 1,173,367 | 1,047,394 | 1,690,455 | 956,674 | 673,218 | 778,573 |
| total assets | 1,909,164 | 1,596,729 | 1,396,030 | 1,119,811 | 1,131,955 | 885,990 | 991,876 | 1,068,235 | 931,315 | 1,173,367 | 1,047,394 | 1,690,455 | 1,018,126 | 860,101 | 1,029,191 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 12,426 | 5,587 | 4,923 | 727 | 9,832 | 1,559 | 2,779 | 2,162 | 2,772 | 281,844 | 277,864 | 914,981 | 338,062 | 413,418 | 395,866 |
| Group/Directors Accounts | 5,001,373 | 3,741,864 | 2,983,821 | 2,325,622 | 1,870,871 | 1,217,732 | 997,118 | 783,578 | 502,167 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 177,273 | 144,976 | 141,112 | 81,725 | 82,062 | 46,243 | 57,804 | 40,596 | 27,593 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 5,191,072 | 3,892,427 | 3,129,856 | 2,408,074 | 1,962,765 | 1,265,534 | 1,057,701 | 826,336 | 532,532 | 281,844 | 277,864 | 914,981 | 338,062 | 413,418 | 395,866 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 98,867 | 98,867 | 173,275 | 166,346 | 170,884 | 75,000 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 98,867 | 98,867 | 173,275 | 166,346 | 170,884 | 75,000 |
| total liabilities | 5,191,072 | 3,892,427 | 3,129,856 | 2,408,074 | 1,962,765 | 1,265,534 | 1,057,701 | 826,336 | 532,532 | 380,711 | 376,731 | 1,088,256 | 504,408 | 584,302 | 470,866 |
| net assets | -3,281,908 | -2,295,698 | -1,733,826 | -1,288,263 | -830,810 | -379,544 | -65,825 | 241,899 | 398,783 | 792,656 | 670,663 | 602,199 | 513,718 | 275,799 | 558,325 |
| total shareholders funds | -3,281,908 | -2,295,698 | -1,733,826 | -1,288,263 | -830,810 | -379,544 | -65,825 | 241,899 | 398,783 | 792,656 | 670,663 | 602,199 | 513,718 | 275,799 | 558,325 |
| Jul 2023 | Jul 2022 | Jul 2021 | Jul 2020 | Jul 2019 | Jul 2018 | Jul 2017 | Jul 2016 | Jul 2015 | Jul 2014 | Jul 2013 | Jul 2012 | Jul 2011 | Jul 2010 | Jul 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | -156,884 | -384,001 | |||||||||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11,282 | 31,236 | 64,206 | 60,373 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | -9,872 | |||||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -505,499 | 191,036 | -168,906 | 483,369 |
| Debtors | 292,827 | 232,033 | 258,413 | -15,215 | 225,511 | -48,278 | -94,365 | 108,893 | -183,305 | 232,209 | -626,247 | 1,282,400 | -57,934 | -18,561 | 265,839 |
| Creditors | 6,839 | 664 | 4,196 | -9,105 | 8,273 | -1,220 | 617 | -610 | -279,072 | 3,980 | -637,117 | 576,919 | -75,356 | 17,552 | 395,866 |
| Accruals and Deferred Income | 32,297 | 3,864 | 59,387 | -337 | 35,819 | -11,561 | 17,208 | 13,003 | 27,593 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | -253,384 | -462,047 | |||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 1,259,509 | 758,043 | 658,199 | 454,751 | 653,139 | 220,614 | 213,540 | 281,411 | 502,167 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -98,867 | 0 | -74,408 | 6,929 | -4,538 | 95,884 | 75,000 |
| share issue | |||||||||||||||
| interest | 0 | 0 | |||||||||||||
| cash flow from financing | 281,411 | 403,300 | |||||||||||||
| cash and cash equivalents | |||||||||||||||
| cash | 19,608 | -31,334 | 17,806 | 3,071 | 20,454 | -57,608 | 18,006 | 28,027 | -58,747 | -106,236 | -16,814 | -43,120 | 150,354 | 82,112 | 29,365 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 19,608 | -31,334 | 17,806 | 3,071 | 20,454 | -57,608 | 18,006 | 28,027 | -58,747 | -106,236 | -16,814 | -43,120 | 150,354 | 82,112 | 29,365 |
enzo life sciences (uk) limited Credit Report and Business Information
Enzo Life Sciences (uk) Limited Competitor Analysis
Perform a competitor analysis for enzo life sciences (uk) limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in EX2 area or any other competitors across 12 key performance metrics.
enzo life sciences (uk) limited Ownership
ENZO LIFE SCIENCES (UK) LIMITED group structure
Enzo Life Sciences (Uk) Limited has no subsidiary companies.
Ultimate parent company
ENZO BIOCHEM INC
#0117715
2 parents
ENZO LIFE SCIENCES (UK) LIMITED
02584159
enzo life sciences (uk) limited directors
Enzo Life Sciences (Uk) Limited currently has 1 director, Ms Kara Cannon serving since Sep 2023.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Ms Kara Cannon | United Kingdom | 56 years | Sep 2023 | - | Director |
P&L
July 2023turnover
717.3k
+33%
operating profit
-988.5k
0%
gross margin
47.2%
-0.58%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
July 2023net assets
-3.3m
+0.43%
total assets
1.9m
+0.2%
cash
54.9k
+0.55%
net assets
Total assets minus all liabilities
Similar Companies
enzo life sciences (uk) limited company details
company number
02584159
Type
Private limited with Share Capital
industry
72190 - Other research and experimental development on natural sciences and engineering
incorporation date
February 1991
age
34
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
July 2023
previous names
affiniti research products limited (January 2009)
accountant
THOMPSON JENNER LLP
auditor
-
address
1 colleton crescent, exeter, devon, EX2 4DG
Bank
BARCLAYS BANK PLC
Legal Advisor
-
enzo life sciences (uk) limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to enzo life sciences (uk) limited. Currently there are 2 open charges and 0 have been satisfied in the past.
enzo life sciences (uk) limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ENZO LIFE SCIENCES (UK) LIMITED. This can take several minutes, an email will notify you when this has completed.
enzo life sciences (uk) limited Companies House Filings - See Documents
| date | description | view/download |
|---|
